AI in Drug Development

Researchers at Ohio State University have developed an AI model named Cure that predicts drug treatment effectiveness without the need for clinical trials. Trained on de-identified health records from over 3 million patients, this innovative model outperforms seven leading AI models by 7-8% in key benchmarks. The implications of this technology could significantly streamline drug testing and enhance our understanding of patient responses to treatments.